The first public company supporting the testing of diagnostic and therapeutic agents
Fase 1 srl is a capital company created by the Region of Sardinia to pursue the clinical development of new diagnostic and therapeutic agents. The company is adequately funded for achievement of its aims, and its activities are coordinated by the Office of the President of the Region of Sardinia.
Fase 1 has the following aims:
- Pre-and post-patenting selection and enhancement of new diagnostic and therapeutic agents
- Clinical development of medicinal drugs and new therapeutic formulations and applications
- Development of procedures and services supporting diagnosis, prognosis and treatment
- Support for the development, production and marketing of biotech, pharmaceutical and veterinary products.
Fase 1 has the following aims:
- Pre-and post-patenting selection and enhancement of new diagnostic and therapeutic agents
- Clinical development of medicinal drugs and new therapeutic formulations and applications
- Development of procedures and services supporting diagnosis, prognosis and treatment
- Support for the development, production and marketing of biotech, pharmaceutical and veterinary products.
